This case involves a postmenopausal, 55-year-old woman with a node-negative cancer considered to be a medullary carcinoma. The tumor is ER- and PR-positive and poorly differentiated (grade 3). She has ...
Patients eligible for this multicenter, phase II trial had metastatic poorly differentiated neuroendocrine carcinoma and had received no previous treatment. Patients with a variety of known primary ...
Nerve Growth Factor Expression Correlates With Perineural Invasion and Pain in Human Pancreatic Cancer PURPOSE: Recent studies suggest the existence of a distinct class of poorly differentiated large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results